The differential influence of life stress on individual symptoms of depression by Fried, E. I. et al.
The differential influence of life stress on
individual symptoms of depression
Fried EI, Nesse RM, Guille C, Sen S. The differential influence of life
stress on individual symptoms of depression.
Objective: Life stress consistently increases the incidence of major
depression. Recent evidence has shown that individual symptoms of
major depressive disorder (MDD) differ in important dimensions such
as their genetic and etiological background, but the impact of stress on
individual MDD symptoms is not known. Here, we assess whether
stress affects depression symptoms differentially.
Method: We used the chronic stress of medical internship to examine
changes of the nine Diagnostic and Statistical Manual (DSM)-5
criterion symptoms for depression in 3021 interns assessed prior to and
throughout internship.
Results: All nine depression symptoms increased in response to stress
(all P < 0.001), on average by 173%. Symptom increases differed
substantially from each other (P < 0.001), with psychomotor problems
(289%) and interest loss (217%) showing the largest increases, and
suicidal ideation (146%) and sleep problems (52%) the smallest.
Symptoms also differed in their severities under stress (P < 0.001):
Fatigue, appetite problems and sleep problems were most prevalent;
psychomotor problems and suicidal ideation were least prevalent.
Conclusion: Stress differentially affects the DSM-5 depressive
symptoms. Analyses of individual symptoms reveal important insights
obfuscated by sum-scores.
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Significant outcomes
• While all MDD symptoms increase in response to internship stress, symptoms differ dramatically in
magnitude of increases.
• MDD symptoms show pronounced prevalence differences under stress.
Limitations
• Internship stress is a particular stressor in a fairly homogeneous population, and extrapolation to the
general population and other stressors should be performed with caution.
• This study did not assess the direction of depressive symptoms with complex natures (e.g. hypersom-
nia vs. insomnia).
Introduction
Major depressive disorder (MDD) is a highly het-
erogeneous disorder (1–3). The Diagnostic and
Statistical Manual (DSM-5) (4) uses nine symp-
toms to define depression, three of which are com-
prised of opposite symptoms (e.g. ‘insomnia or
hypersomnia’), leading to 1497 unique symptom
profiles that qualify for the same diagnosis (5). In
line the with the National Institute for Mental
Health (NIMH) strategic plan for mood disorder
research (6), a growing body of evidence suggests
that the analysis of individual depression symp-
toms is an untapped source of important and clini-
cally relevant data. For instance, MDD symptoms
differ from each other in their genetic (7–9) and
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etiological (10) background, differentially impact
impairment of psychosocial functioning (11) and
show differential associations with important clini-
cal variables such as demographic information,
personality traits, life events and lifetime comor-
bidities (12).
Life stress is one of the most robust triggers for
MDD (13,14). Elevated levels of depression after
experiencing stress have been documented both in
patients and general population samples (14,15),
with depression rates 2.5–7 times higher for indi-
viduals exposed to serious stressors (16,17).
Despite the overwhelming evidence that depression
diagnoses are increased in the context of stress, we
know little about the behaviour of individual
depressive symptoms in response to stress.
Here, we prospectively investigate the impact of
life stress on the nine DSM MDD criterion symp-
toms in a cohort study of interns. Internship is a
well-established serious chronic stressor, and
interns are faced with long work hours, sleep depri-
vation, loss of autonomy, as well as extreme emo-
tional situations (18,19). In a previous longitudinal
study of interns, depression levels increased from
3.9% at baseline to 25.7% during internship (20).
Utilizing internship as prospective stress model
offers the opportunity to assess depression symp-
toms in a large sample before and after the reliable
onset of severe chronic stress.
Aims of the study
The present report uses a cohort of 3021 interns to
examine whether internship stress impacts some
depression symptoms more strongly than others,
as well as the magnitude of potential differences.
Material and methods
Sample
Seven thousand and four hundred and twenty-nine
interns entering internship programmes in the USA
during the 2007–2012 academic years were invited
to participate in the study; 59% (N = 4383) accepted
the invitation. The institutional review boards at
participating hospitals approved the study. Partici-
pating subjects provided electronic informed consent
and were given $50 in gift certificates.
Assessment
All surveys were conducted through a secure
online Web site designed to maintain confidential-
ity. Depressive symptoms were measured using the
Patient Health Questionnaire (PHQ-9) (21). The
PHQ-9 is a self-report component of the PRIME-
MD inventory that screens for the DSM-5 crite-
rion symptoms of depression. For each of the nine
symptoms, subjects indicated whether, during the
previous 2 weeks, the symptom had bothered them
‘not at all’, ‘several days’, ‘more than half the days’
or ‘nearly every day’. Each item yields a score of 0,
1, 2 or 3. The nine symptoms assessed by the PHQ-
9 are as follows: ‘little interest or pleasure in doing
things’ (interest), ‘feeling depressed or hopeless’
(mood), ‘sleep problems’ (sleep), ‘feeling tired’
(fatigue), ‘appetite problems’ (appetite), ‘feeling
bad about yourself/that you are a failure’ (self-
blame), ‘trouble concentrating on things’ (concen-
tration), ‘moving or speaking slowly/being fidgety
or restless’ (psychomotor) and ‘suicidal ideation’
(suicide).
Subjects completed a baseline survey 1–
2 months prior to commencing internship that
assessed general demographic factors (age, sex)
and depressive symptoms (PHQ-9). Participants
were contacted via email 3, 6, 9 and 12 months
into their internship year and asked to complete
the PHQ-9 again.
Statistical analysis
We compared symptom severity at baseline with
average symptom severity during the four mea-
surements across the internship. This approach has
been used in previous publications based on this
dataset (10,20) and has the advantage of increased
reliability of symptom assessment within intern-
ship through repeated measurement. When averag-
ing the within-internship symptom scores, 1362
(31.1%) of the 4383 subjects were dropped via list-
wise deletion because they had missing data on
two or more time points, leaving 3021 interns in
the analytic sample.
Overall, three analyses were performed. First,
we investigated whether PHQ-9 symptoms
increased with stress. We used one paired samples
t-test per symptom to compare severities and
adjusted P-values for multiple testing using the
Bonferroni correction.
Second, we tested whether symptoms differed
from each other in response to stress, a test to
assess whether stress had differential impacts on
specific depressive symptoms. Instead of perform-
ing 36 individual tests comparing each symptom
increase against all other symptom increases, we
conducted one omnibus test. We fitted two longitu-
dinal mixed models to the data with the subject
variable as a random effect, using the LMER func-
tion of the R-package LME4 (22). In model I, symp-
tom increases from baseline to the stress condition
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were allowed to be freely estimated, whereas
increases were constrained to be equal in model II
(i.e. slopes were forced to be equal). We then exam-
ined whether the constrained model II showed sig-
nificantly decreased model fit compared with
model I, as would be expected if symptoms
increased differentially in response to stress. We
compared models using a chi-squared difference
test and used the Bayesian information criterion
(BIC) (23) as goodness-of-fit statistic (the lower the
value, the better the fit).
Third, we examined the stress condition symp-
tom score to see whether the nine depressive symp-
toms differed in their severities after stress onset.
Similar to analysis two, we performed one omni-
bus test by fitting two mixed models to the cross-
sectional data of timepoint two using the LMER
function of the R-package LME4, once again using
the subject variable as random effect. Model I
allowed for a free estimation of symptom severi-
ties, while model II constrained all symptoms to
have equal severities. Model fit was compared sim-
ilar to analysis two.
Lastly, we provide detailed descriptive informa-
tion about symptom severity and increases. Analy-
sis one was performed using SPSS v21.0 (24) and
analyses two and three with R v3.1.0 (25). We con-
sider P-values of <0.05 significant.
Results
Sample characteristics
Three thousand and twenty-one individuals were
included in the analyses; 48.4% of the study partic-
ipants were males, and the mean age was 27.5
(SD = 2.7) (Table 1). Participants that were
dropped due to missing values did not differ signifi-
cantly from the retained participants regarding the
variables age, sex or history of depression (all
P > 0.05).
Symptom increases
All symptoms increased significantly over time (t-
values between 12.3 and 57.6, all P < 0.001)
(Table 2) (Fig. 1). Symptoms increased by an aver-
age of 173.4%, ranging from 51.5% (sleep) to
289.2% (psychomotor) (Fig. 2).
Symptoms differed in their increases: Model I
(variable symptom increases across time) fits the
data significantly better than model II (equal
symptom increases across time) (v2diff = 2652,
dfdiff = 8, P < 0.001) (Table 3). This means that
stress had differential impact on the nine depres-
sive symptoms.
Symptoms under stress
Model I (variable symptom severities under
stress) showed a superior fit compared with
model II (equal symptom severities under stress)
(v2diff = 13 644, dfdiff = 8, P < 0.001) (Table 3).
The three symptoms fatigue (Mean = 1.40),
appetite (M = 0.93) and sleep (M = 0.82) showed
the highest mean severity under stress, while the
two symptoms, suicide (M = 0.10) and psycho-
motor (M = 0.23), showed the lowest mean
severity.
Discussion
The present study examined the impact of chronic
stress on the nine DSM-5 criterion symptoms for
depression by prospectively assessing a population
Table 1. Demographic characteristics of study participants
Variable Number (%)
Sex
Male 1462 (48.4)
Female 1559 (52.6)
Age, years
≤25 536 (17.7)
26–30 2146 (71)
31–35 281 (9.3)
>35 58 (<0.1)
History of depression
Yes 1326 (43.9)
No 1693 (55.1)
Specialty
Internal medicine 1106 (36.6)
Other 394 (13)
Pediatrics 350 (11.6)
General surgery 306 (10.1)
Psychiatry 217 (7.2)
Emergency medicine 197 (6.5)
Family medicine 137 (4.5)
Obstetrics/gynecology 123 (4.1)
Internal medicine/pediatrics 73 (2.4)
Neurology 48 (1.6)
Transitional 43 (1.4)
Missing 27 (0.9)
Table 2. Symptom severities and increases
n = 3021
Baseline Under stress Increases
Mean SD Mean SD % P
Interest 0.21 0.48 0.66 0.57 216.5 < 0.001
Mood 0.24 0.48 0.64 0.59 168.3 < 0.001
Sleep 0.54 0.73 0.82 0.71 51.5 < 0.001
Fatigue 0.57 0.69 1.40 0.70 145.4 < 0.001
Appetite 0.35 0.64 0.93 0.77 164.4 < 0.001
Self-blame 0.21 0.50 0.58 0.64 175.0 < 0.001
Concentration 0.17 0.47 0.52 0.62 204.4 < 0.001
Psychomotor 0.06 0.29 0.23 0.42 289.2 < 0.001
Suicide 0.04 0.21 0.10 0.27 146.0 < 0.001
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of 3021 individuals before and after the onset of
medical internship. While all symptoms increased
during internship, the impact of stress varied dra-
matically across symptoms, with some symptoms
increasing substantially more than others; espe-
cially, psychomotor problems, loss of interest and
concentration problems exhibited pronounced
increases. The somatic symptoms fatigue, appetite
and sleep problems were most prevalent under
stress.
Prior studies have focused on the relationship
between stress and depression subtypes, but no
clear pattern has emerged (26–28). This inconsis-
tency is likely due to problems pertaining to the
validity of MDD subtypes (29,30), a reliance on
retrospective self-report of life stress that can be
substantially biased (31,32), and a cross-sectional
design that confounds the bidirectional influences
of life stress and depression (14). The current study
addresses these limitations, with a prospective
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Fig. 1. Depression symptoms at
baseline and under stress.
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Fig. 2. Symptom change over time.
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design that allows for a causal interpretation:
Stress leads to substantial and heterogeneous
increases of depressive symptoms.
Implications
The present report documents substantial variabil-
ity in symptom change across time and symptom
severity under stress. This work adds to a growing
body of evidence illuminating important differ-
ences between individual symptoms of depression
(7,10,33) and indicates that the reliance on sum-
scores and thresholds obfuscates crucial informa-
tion about the nature of depressive symptoms. This
covert heterogeneity may help to explain recent
‘disappointing’ findings such as low reliability for
MDD diagnoses in the DSM-5 field trials (34), low
antidepressant efficacy compared with placebo
response (35), lack of common genetic markers
associated with antidepressant response (36) and
failure to detect even small genetic effects with
depression diagnosis in large genomewide associa-
tion studies (37).
The investigation of individual symptoms
reveals clinically useful insights. For instance,
about 72% of the interns in our study reported
sleep problems on at least several days per week
under stress. Sleep problems are a well-established
predictor for the development of future episodes of
depression (38), decrease treatment efficacy
(39,40), and directly targeting sleep problems in
depressed patients may increase overall depression
improvement (41,42). We believe that utilizing
symptom information is a crucial step toward the
development of more efficient prevention and
intervention strategies and may help us understand
underlying biological processes better than diagno-
sis level analyses.
The DSM criterion symptoms assessed in this
study are only a small subset of potential MDD
symptoms (43) and were largely determined by
clinical consensus instead of empirical evidence
(12). Various other symptoms, including anxiety,
irritability and anger, are prevalent among individ-
uals diagnosed with MDD and may have great
value in predicting the course of the disease
(44,45). Assessing symptoms outside of traditional
DSM criteria could advance future studies of stress
and depression as well as treatment of patients,
and is in line with the National Institute of Mental
Health finding that strictly adhering to DSM diag-
nostic criteria may be inhibiting progress in eluci-
dating the biological roots of mental illness (46). A
recent study also documented that specific dimen-
sions of rating scales for depression, such as the 6-
item melancholia subscale of the 17-item Hamilton
Rating Scale for Depression (HAM-D17) (47,48),
are more sensitive to treatment response than large
multidimensional scales (49). The authors con-
cluded that such subscales may possess greater bio-
logical validity and thus circumvent problems of
heterogeneity inherent to most depression rating
scales.
Limitations
The present report has three limitations. First,
we only investigated symptom change in
response to one specific stressor. While the par-
ticular pattern of symptom change is likely to
be different with different stressors, the results of
this study and others (50–52) suggest that it is
unlikely that other stressors will uniformly
increase the prevalence of all depressive symp-
toms equally. Second, interns are not a represen-
tative sample, so extrapolation to the general
population should be performed with caution.
Third, the PHQ-9 neither assesses the direction
of depressive symptoms with complex natures
(e.g. hypersomnia or insomnia instead of sleep
problems) nor MDD symptoms outside of the
DSM-5 criteria.
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Table 3. Chi-squared difference tests for the two model comparisons
df BIC v2diff dfdiff P
Differential symptom change
Model I† 20 275 106
Model II‡ 12 277 680 2662 8 <0.001
Differential symptom severity
Model I§ 11 137 110
Model II¶ 3 150 530 13 502 8 <0.001
df, degrees of freedom; BIC, Bayesian information criterion; v2diff , chi-squared statis-
tic of the chi-squared difference test; dfdiff, degrees of freedom of the chi-squared
difference test; P, P-value of the chi-squared difference test.
†Variable symptom increases across time.
‡Equal symptom increases across time.
§Variable symptom severities after stress onset.
¶Equal symptom severities after stress onset.
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